CD274 and colorectal carcinoma: Emerging evidence suggests that the stratification of colorectal cancer microenvironment based on tumor-infiltrating lymphocytes (TILs) and CD274 expression is a biomarker and strong predictor of disease recurrence and survival in patients with CRC (34).